JAMES INVESTMENT RESEARCH INC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 5 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JAMES INVESTMENT RESEARCH INC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$494,905
+22.4%
18,1650.0%0.06%
+25.0%
Q2 2023$404,171
+102742.5%
18,1650.0%0.05%0.0%
Q1 2023$393
+56.6%
18,165
+47.1%
0.05%
+48.6%
Q4 2022$251
-99.9%
12,345
+53.3%
0.04%
+20.7%
Q3 2022$206,000
+7.9%
8,0510.0%0.03%
+11.5%
Q2 2022$191,000
-91.6%
8,051
-93.1%
0.03%
-65.8%
Q3 2017$2,266,000117,4000.08%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 5,188,417$85,349,0007.80%
TANAKA CAPITAL MANAGEMENT INC 144,602$2,379,0005.69%
INGALLS & SNYDER LLC 6,817,540$112,149,0005.47%
NEXTHERA CAPITAL LP 1,045,196$17,193,0002.83%
Timpani Capital Management LLC 245,279$4,035,0001.41%
S&T BANK/PA 426,257$7,012,0001.25%
SHAKER INVESTMENTS LLC/OH 107,670$1,771,0001.10%
ESSEX INVESTMENT MANAGEMENT CO LLC 434,624$7,150,0000.94%
AMI ASSET MANAGEMENT CORP 709,300$11,668,0000.83%
Birchview Capital, LP 75,500$1,242,0000.82%
View complete list of CORCEPT THERAPEUTICS INC shareholders